Peripheral Neuropathy Market Analysis

Medical Cold Gel Market to Reach USD 1.8 Billion by 2033 at 5.2% CAGR

The fastest-growing indication by CAGR (Claritas model), directly supported by NCT06488963 (Koç University). If this trial demonstrates statistically significant symptomatic benefit from cold therapy devices — and protocol extension to gel-based application follows — peripheral neuropathy could become a formalized indication within 3–5 years, opening labeled use in a patient population numbering in the tens of millions globally.